<b><i>Background:</i></b> Amnestic mild cognitive impairment (aMCI) is regarded as a prodromal stage of Alzheimer’s disease (AD). Given that patients with early-onset AD (EOAD) and with late-onset AD (LOAD) are known to have different clinical courses, symptoms and neuroimaging findings, early-onset (EOMCI) and late-onset aMCI (LOMCI) might be expected to have similar differences as EOAD versus LOAD. <b><i>Methods:</i></b> Our study involving 425 patients with aMCI (124 EOMCI, 301 LOMCI), who were followed for around 1.5 years, and 958 normal control subjects (NC) investigated neuropsychological characteristics and prediction of progression to AD in patients with EOMCI versus LOMCI. Neuropsychological scores were compared between EOMCI, LOM...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Background and purposeDisappointing outcomes from clinical trials involving amyloid-modifying therap...
<b><i>Background: </i></b>Several structural brain changes have been associated with Alzheimer’s dis...
<p><b><i>Background/Aims:</i></b> To evaluate whether visual assessment of medial temporal lobe atr...
Background: Despite having the same histopathological characteristics, early-onset and late-onset Al...
<b><i>Background:</i></b> The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) dev...
Despite having the same histopathological characteristics, early-onset and late-onset Alzheimer’s d...
Despite having the same histopathological characteristics, early-onset and late-onset Alzheimer’s d...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Context: The likelihood of conversion to Alzheimer disease (AD) in mild cognitive impairment (MCI) a...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Background and purposeDisappointing outcomes from clinical trials involving amyloid-modifying therap...
<b><i>Background: </i></b>Several structural brain changes have been associated with Alzheimer’s dis...
<p><b><i>Background/Aims:</i></b> To evaluate whether visual assessment of medial temporal lobe atr...
Background: Despite having the same histopathological characteristics, early-onset and late-onset Al...
<b><i>Background:</i></b> The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) dev...
Despite having the same histopathological characteristics, early-onset and late-onset Alzheimer’s d...
Despite having the same histopathological characteristics, early-onset and late-onset Alzheimer’s d...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Context: The likelihood of conversion to Alzheimer disease (AD) in mild cognitive impairment (MCI) a...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
Introduction: Progression of amnestic mild cognitive impairment (aMCI) to Alzheimer’s disease (AD) i...
Background and purposeDisappointing outcomes from clinical trials involving amyloid-modifying therap...